VistaGen Therapeutics
VTGN
VTGN
34 hedge funds and large institutions have $15.7M invested in VistaGen Therapeutics in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
3% more funds holding
Funds holding: 33 → 34 (+1)
8% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 12
Holders
34
Holding in Top 10
–
Calls
$4.96M
Puts
$835K
Top Buyers
| 1 | +$8.25M | |
| 2 | +$1.2M | |
| 3 | +$726K | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$524K |
| 5 |
BCM
BML Capital Management
Zionsville,
Indiana
|
+$524K |
Top Sellers
| 1 | -$796K | |
| 2 | -$441K | |
| 3 | -$107K | |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
-$89.2K |
| 5 |
BlackRock
New York
|
-$88.9K |